Structure-activity relationships of synthetic coumarins as HIV-1 inhibitors

Bioinorganic Chemistry and Applications

Volumn 2006, Issue , 2006, Pages

  Kostova, I ^a   Raleva, S ^b   Genova, P ^b   Argirova, R ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645235123     PISSN: 15653633     EISSN: 1687479X     Source Type: Journal    
DOI: 10.1155/BCA/2006/68274     Document Type: Article

References (38)

1. Lee K-H, Morris-Natschke S. Recent advances in the discovery and development of plant-derived natural products and their analogs as anti-HIV agents. Pure and Applied Chemistry. 1999;71(6):1045-1052.
2. Kashman Y, Gustafson KR, Fuller RW, et al. HIV inhibitory natural products. Part 7. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. Journal of Medicinal Chemistry. 1992;35(15):2735-2743.
3. Creagh T, Ruckle JL, Tolbert DT, et al. Safety and pharmacokinetics of single doses of (+)-calanolide A, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects. Antimicrobial Agents and Chemotherapy. 2001;45(5):1379-1386.
4. Xu Z-Q, Flavin MT, Jenta TR. Calanolides, the naturally occurring anti-HIV agents. Current Opinion in Drug Discovery & Development. 2000;3(2):155-166.
5. Flavin MT, Rizzo JD, Khilevich A, et al. Synthesis, Chromatographic resolution, and anti-human immunodeficiency virus activity of (±)-calanolide A and its enantiomers. Journal of Medicinal Chemistry. 1996;39(6):1303-1313.
6. Kucherenko A, Flavin MT, Boulanger WA, et al. Novel approach for synthesis of (±)-calanolide A and its anti-HIV activity. Tetrahedron Letters. 1995;36(31):5475-5478.
7. Rehder K, Kepler J. Total synthesis of (+)-calanolide A. Synthetic Communications. 1996;26(21):4005-4021.
8. Huang L, Kashiwada Y, Cosentino LM, et al. Anti-AIDS agents. 15. Synthesis and anti-HIV activity of dihydroseselins and related analogs. Journal of Medicinal Chemistry. 1994;37(23):3947-3955.
9. Yang Z-Y, Xia Y, Xia P, Brossi A, Cosentino LM, Lee K-H. Anti-AIDS agents. Part 41: synthesis and anti-HIV activity of 3′,4′-di-o-(-)- camphanoyl-(+)-cis-khellactone (DCK) lactam analogues. Bioorganic & Medicinal Chemistry Letters. 2000;10(10):1003-1005.
10. Xie L, Takeuchi Y, Cosentino LM, McPhail AT, Lee K-H. Anti-AIDS agents. 42. Synthesis and anti-HIV activity of disubstituted (3′ R,4′R)-3′ ,4′-Di-O-(S)-camphanoyl-(+)-cis-khellactone analogues. Journal of Medicinal Chemistry. 2001;44(5):664-671.
11. Xie L, Yu D, Wild C, et al. Anti-AIDS agents. 52. Synthesis and anti-HIV activity of hydroxymethyl (3′ R,4′ R)-3′ ,4′-Di-O-(S)- camphanoyl-(+)-cis-khellactone derivatives. Journal of Medicinal Chemistry. 2004;47(3):756-760.
12. Xie L, Takeuchi Y, Cosentino LM, Lee K-H. Anti-AIDS agents. 37. Synthesis and structure-activity relationships of (3′ R,4′ R)-(+)-cis-khellactone derivatives as novel potent anti-HIV agents. Journal of Medicinal Chemistry. 1999;42(14):2662-2672.
13. Xie L, Allaway G, Wild C, Kilgore N, Lee K-H. Anti-AIDS agents. Part 47: Synthesis and anti-HIV activity of 3-substituted 3′,4′-Di-O-(S)- camphanoyl-(3′ R,4′ R)-(+)-cis-khellactone derivatives. Bioorganic & Medicinal Chemistry Letters. 2001;11(17):2291-2293.
14. Zembower DE, Liao S, Flavin MT, et al. Structural analogues of the calanolide anti-HIV agents. Modification of the trans10,11-dimethyldihydropyran- 12-ol ring (ring C). Journal of Medicinal Chemistry. 1997;40(6):1005-1017.
15. Chenera B, West ML, Finkelstein JA, Dreyer GB. Total synthesis of (±)-calanolide A, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. The Journal of Organic Chemistry. 1993;58(21):5605-5606.
16. 14C-labeled (+)-calanolide A, a naturally occurring anti-HIV agent. Journal of Labelled Compounds and Radiopharmaceuticals. 1997;39(11):901-906.
17. Khilevich A, Mar A, Flavin MT, et al. Synthesis of (+)-calanolide A, an anti-HIV agent, Via enzyme-catalyzed resolution of the aldol products. Tetrahedron: Asymmetry. 1996;7(11):3315-3326.
18. Galinis DL, Fuller RW, McKee TC, et al. Structure-activity modifications of the HIV-1 inhibitors (+)-calanolide A and (-)-calanolide B. Journal of Medicinal Chemistry. 1996;39(22):4507-4510.
19. Khilevich A, Rizzo J, Flavin MT, et al. A versatile approach for synthesis of 2,3-dimethyl chroman-4-ones, intermediate for calanolide Anti-HIV agents, via aldol/mitsunobu reactions. Synthetic Communications. 1996;26(20):3757-3771.
20. Palmer CJ, Josephs JL. Synthesis of the Calophyllum coumarins. Part 2. Journal of the Chemical Society. Perkin Transactions 1. 1995;(24):3135-3152.
21. Palmer CJ, Josephs JL. Synthesis of the calophyllum coumarins. Tetrahedron Letters. 1994;35(30):5363-5366.
22. Xu Z-Q, Kern ER, Westbrook L, et al. Plant-derived and semi-synthetic calanolide compounds with in vitro activity against both human immunodeficiency virus type 1 and human cytomegalovirus. Antiviral Chemistry & Chemotherapy. 2000;11(1):23-29.
23. Cardellina JH II, Bokesch HR, McKee TC, Boyd MR. Resolution and comparative anti-HIV evaluation of the enantiomers of calanolides A and B. Bioorganic & Medicinal Chemistry Letters. 1995;5(9):1011-1014.
24. Deshpande PP, Tagliaferri F, Victory SF, Yan S, Baker DC. Synthesis of optically active calanolides A and B. The Journal of Organic Chemistry. 1995;60(10):2964-2965.
25. McKee TC, Cardellina JH II, Dreyer GB, Boyd MR. The pseudocalanolides: structure revision of calanolides C and D. Journal of Natural Products. 1995;58(6):916-920.
26. Xu Z-Q, Buckheit RW Jr, Stup TL, et al. In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI. Bioorganic & Medicinal Chemistry Letters. 1998;8(16):2179-2184.
27. Yu D, Suzuki M, Xie L, Morris-Natschke SL, Lee K-H. Recent progress in the development of coumarin derivatives as potent anti-HIV agents. Medicinal Research Reviews. 2003;23(3):322-345.
28. Martyanov IV, Zakharova OD, Sottofattori E, et al. Interaction of oligonucleotides conjugated to substituted chromones and coumarins with HIV-1 reverse transcriptase. Antisense & Nucleic Acid Drug Development. 1999;9(5):473-480.
29. Martyanov IV, Zakharova OD, Sottofattori E, et al. HIV-1 reverse transcriptase is capable of elongating derivatives of sequence specific noncomplementary oligodeoxynucleotides. Biochemistry and Molecular Biology International. 1998;45(5): 857-864.
30. Ishikawa T, Kotake K, Ishii H. Synthesis of toddacoumaquinone, a coumarin-naphthoquinone dimer, and its antiviral activities. Chemical & Pharmaceutical Bulletin. 1995;43(6):1039-1041.
31. El-Subbagh HI, Abu-Zaid SM, Mahran MA, Badria FA, Al-Obaid AM. Synthesis and biological evaluation of certain α, β-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents. Journal of Medicinal Chemistry. 2000;43(15):2915-2921.
32. Bourinbaiar AS, Tan X, Nagorny R. Inhibitory effect of coumarins on HIV-1 replication and cell-mediated or cell-free viral transmission. Acta Virologica. 1993;37(4):241-250.
33. Zhao H, Neamati N, Hong H, et al. Coumarin-based inhibitors of HIV integrase. Journal of Medicinal Chemistry. 1997;40(2):242-249.
34. Wang HX, Ng TB. Examination of lectins, polysaccharopeptide, polysaccharide, alkaloid, coumarin and trypsin inhibitors for inhibitory activity against human immunodeficiency virus reverse transcriptase and glycohydrolases. Planta Medica. 2001;67(7):669-672.
35. Mao PC-M, Mouscadet J-F, Leh H, Auclair C, Hsu L-Y. Chemical modification of coumarin dimer and HIV-1 integrase inhibitory activity. Chemical & Pharmaceutical Bulletin. 2002;50(12):1634-1637.
36. Lunney EA, Hagen SE, Domagala JM, et al. A novel nonpeptide HIV-1 protease inhibitor: elucidation of the binding mode and its application in the design of related analogs. Journal of Medicinal Chemistry. 1994;37(17):2664- 2677.
37. Kirkiacharian S, Thuy DT, Sicsic S, Bakhchinian R, Kurkjian R, Tonnaire T. Structure - activity relationships of some 3-substituted-4-hydroxycoumarins as HIV-1 protease inhibitors. IL Farmaco. 2002;57(9):703-708.
38. Reboud-Ravaux MC, Boggetto ND, Doucet CE, et al. Synthetic inhibitors targeting serine and aspartic acid proteases [in French]. Journal de Pharmacie de Belgique. 1996;51(3):161-164.